Skip to content

cobas Cdiff Test

by Roche Molecular Systems, Inc.

510(k) K142422

cobas Cdiff Test is a medical device (FDA Class II; FDA product code OZN, C. Difficile Toxin Gene Amplification Assay) made by Roche Molecular Systems, Inc., cleared under FDA 510(k) K142422 on 20 May 2015, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK142422 Date20 May 2015ClearedStatusActive

Official records

From the FDA record

Received by the FDA
28 Aug 2014
FDA decision
20 May 2015 (Substantially Equivalent)
FDA review time
265 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K142422 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
OZN
Device class
Class II
Regulation
21 CFR Part 866.3130
Advisory committee
Microbiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code OZN (C. Difficile Toxin Gene Amplification Assay).

Other devices from Roche Molecular System, Inc.

See all devices from Roche Molecular System, Inc. →